Novo Nordisk nach Split WKN: A3EU6F ISIN: DK0062498333 Forum: Aktien User: Coronaprofiteur

38,34 EUR
-1,86 % -0,73
9. September 2026, 23:01 Uhr, L&S Exchange
Kommentare 56.431
joe46
joe46, 27. Aug 11:30 Uhr
0

+5% 15:30

Das wäre super 👍
csl1234
csl1234, 27. Aug 11:38 Uhr
0

Ja ich glaube er ist da mit jpm durcheinander gekommen, die haben an dem Tag auf 275 erhöht

Die 275 waren in der Meldung von Finwire und wurden von Marketscreener übernommen. Siehe zB. hier: *** https://de.marketscreener.com/boerse-nachrichten/deutsche-bank-stuft-novo-nordisk-auf-verkaufen-herab-halten-kursziel-265-daenische-kronen-275-ce7858ded98ff625
HH1978
HH1978, 27. Aug 13:00 Uhr
0
Ich glaube nicht, dass es heute ein schönes Plus gibt, warum die Amys hoch kaufen nachdem Trump wieder gesagt hat die Medikamente müssten günstiger werden. Ich glaube eher heute gibt’s ein dickes minus
T
Tsindu12, 27. Aug 13:10 Uhr
1
Was auffällt auch in letzter Zeit wie sehr Retatrutide in Social Media gepusht wird, obwohl es noch nicht mal zugelassen ist. Jeder Body Builder Influencer und Bio Hacker benutzt das und ist begeistert. Der Peptid Schwarzmarkt ist riesig. Wenn Novo da nicht bald mal mitzieht wird es richtig dunkel
S
Siga, 27. Aug 13:24 Uhr
2
Novo Nordisk sued Eli Lilly on July 21, accusing it of falsely advertising Zepbound and its diabetes treatment Mounjaro by ⁠comparing higher ​doses of those products with lower doses of Novo Nordisk's Wegovy ​and Ozempic. A federal judge in Trenton will consider Novo Nordisk's request for a preliminary injunction to halt Eli Lilly's nationwide ads at ​an August 27 hearing.
McLovin09
McLovin09, 27. Aug 11:30 Uhr
0

275 DKK ist falsch, es waren 290DKK. Daher 9% nicht 3%

Ja ich glaube er ist da mit jpm durcheinander gekommen, die haben an dem Tag auf 275 erhöht
S
Stonksstocks, 27. Aug 11:26 Uhr
1
kann mir nicht vorstellen dass amis nicht hochkaufen
csl1234
csl1234, 27. Aug 11:26 Uhr
0

Deutsche Bank’s timing looks questionable. On Aug 25, DB reiterated HOLD on Novo. Just 48 hours later, after NVO attempted a technical breakout, DB suddenly downgraded it to SELL, while only modestly cutting its target from DKK 275 to DKK 265. (Which by the way is 3% only, not 9% what was mentioned by some editors - another manipulation attempt? Maybe...) What fundamentally changed in 48 hours? Most of the cited concerns - the patent cliff, 2027 growth uncertainty and the upcoming Capital Markets Day - were already known when DB reiterated HOLD. Coincidentally, the downgrade arrives right after the breakout attempt and immediately pressures the stock again. This does NOT prove market manipulation, but the timing certainly deserves scrutiny. A rating change this significant based largely on already-known information, only two days after reiterating HOLD, raises legitimate questions. The timing is even more interesting considering the large amount of call options expiring Friday around $47.50, $48 and $48.50. A sharp move below these strikes just before expiration could make a significant number of calls expire worthless. This does not prove manipulation or any connection between DB and the options positioning. But a sudden downgrade based largely on previously known information, just two days after reiterating HOLD and immediately before an option expiration with concentrated calls near the stock price, certainly raises questions about the timing...

275 DKK ist falsch, es waren 290DKK. Daher 9% nicht 3%
S
Stonksstocks, 27. Aug 11:26 Uhr
0
+5% 15:30
Dr.Meyer
Dr.Meyer, 27. Aug 11:24 Uhr
3

Deutsche Bank’s timing looks questionable. On Aug 25, DB reiterated HOLD on Novo. Just 48 hours later, after NVO attempted a technical breakout, DB suddenly downgraded it to SELL, while only modestly cutting its target from DKK 275 to DKK 265. (Which by the way is 3% only, not 9% what was mentioned by some editors - another manipulation attempt? Maybe...) What fundamentally changed in 48 hours? Most of the cited concerns - the patent cliff, 2027 growth uncertainty and the upcoming Capital Markets Day - were already known when DB reiterated HOLD. Coincidentally, the downgrade arrives right after the breakout attempt and immediately pressures the stock again. This does NOT prove market manipulation, but the timing certainly deserves scrutiny. A rating change this significant based largely on already-known information, only two days after reiterating HOLD, raises legitimate questions. The timing is even more interesting considering the large amount of call options expiring Friday around $47.50, $48 and $48.50. A sharp move below these strikes just before expiration could make a significant number of calls expire worthless. This does not prove manipulation or any connection between DB and the options positioning. But a sudden downgrade based largely on previously known information, just two days after reiterating HOLD and immediately before an option expiration with concentrated calls near the stock price, certainly raises questions about the timing...

Marktmanipulation. DB möchte Geld verdienen 🤔 das ist eindeutig. Grund mehr zu kaufen und das Gegenteil zu tun🤑
McLovin09
McLovin09, 27. Aug 11:21 Uhr
0
Deutsche Bank’s timing looks questionable. On Aug 25, DB reiterated HOLD on Novo. Just 48 hours later, after NVO attempted a technical breakout, DB suddenly downgraded it to SELL, while only modestly cutting its target from DKK 275 to DKK 265. (Which by the way is 3% only, not 9% what was mentioned by some editors - another manipulation attempt? Maybe...) What fundamentally changed in 48 hours? Most of the cited concerns - the patent cliff, 2027 growth uncertainty and the upcoming Capital Markets Day - were already known when DB reiterated HOLD. Coincidentally, the downgrade arrives right after the breakout attempt and immediately pressures the stock again. This does NOT prove market manipulation, but the timing certainly deserves scrutiny. A rating change this significant based largely on already-known information, only two days after reiterating HOLD, raises legitimate questions. The timing is even more interesting considering the large amount of call options expiring Friday around $47.50, $48 and $48.50. A sharp move below these strikes just before expiration could make a significant number of calls expire worthless. This does not prove manipulation or any connection between DB and the options positioning. But a sudden downgrade based largely on previously known information, just two days after reiterating HOLD and immediately before an option expiration with concentrated calls near the stock price, certainly raises questions about the timing...
G
GLP1Lover, 27. Aug 11:15 Uhr
2
Das ist doch Unsinn, dass wegen einem arp der Kurs nicht steigt. Wie viele Unternehmen kaufen bei ATHs Aktien zurück
csl1234
csl1234, 27. Aug 11:07 Uhr
0

februar 2027 denke ich

ja, falls sie weiterhin ~ €40Mio p.w. in den Aktienrückkauf investieren.
csl1234
csl1234, 27. Aug 10:56 Uhr
0

Kursziele werden auch häufig aus eigenen Interesse gemacht. Sollte man immer im Hinterkopf haben.

Natürlich. Btw. würde ich es mindest genauso lächerlich finden, wenn sie das Kursziel auf 317 erhöht hätten. == bisheriger Analyse wertlos.
S
Stonksstocks, 27. Aug 10:56 Uhr
0
februar 2027 denke ich
E
Eddieshare21, 27. Aug 10:55 Uhr
0
Solange das ARP nicht abgeschlossen ist, bleibt der Deckel wohl zu. Für Novo also prima. Weiß jemand wann der ARP zu Ende ist?
Mehr zu diesem Wert
Thema
1 Novo Nordisk nach Split
2 Novo Nordisk
Meistdiskutiert
Thema
1 Trading- und Aktien-Chat
2 für alle, die es ehrlich meinen beim Traden.
3 DRONESHIELD LTD Hauptdiskussion -7,52 %
4 Aktuelles zu Almonty Industries -4,13 %
5 DAX / Germany 40 Hauptdiskussion -1,33 %
6 Freunde der Telekom +3,22 %
7 NEL ASA Hauptdiskussion -9,09 %
8 SpaceX-Haupt-Hauptforum -3,86 %
9 RHEINMETALL Hauptdiskussion -4,92 %
10 Olle Kaffeemühle +1,28 %
Alle Diskussionen
Aktien
Thema
1 DRONESHIELD LTD Hauptdiskussion -7,52 %
2 Aktuelles zu Almonty Industries -4,13 %
3 Freunde der Telekom +3,22 %
4 NEL ASA Hauptdiskussion -9,09 %
5 BP Hauptdiskussion +1,55 %
6 SpaceX-Haupt-Hauptforum -3,86 %
7 RHEINMETALL Hauptdiskussion -4,92 %
8 Olle Kaffeemühle +1,28 %
9 Strategy B -2,80 %
10 BioNTech Hauptdiskussion -0,54 %
Alle Diskussionen